| PERIOD ENDING | 30-Oct-09 | 31-Jul-09 | 1-May-09 | 30-Jan-09 | | Total Revenue | 11,376,000 | 13,844,000 | 11,832,000 | 9,984,000 | | Cost of Revenue | 7,485,000 | 9,022,000 | 7,636,000 | 6,616,000 | | | Gross Profit | 3,891,000 | 4,822,000 | 4,196,000 | 3,368,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 2,872,000 | 3,108,000 | 2,944,000 | 2,610,000 | | Non Recurring | 11,000 | 14,000 | 13,000 | 32,000 | | Others | 403,000 | 408,000 | 401,000 | 397,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 374,000 | 1,292,000 | 838,000 | 329,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| 5,000 | 5,000 | 18,000 | | Earnings Before Interest And Taxes | 364,000 | 1,297,000 | 843,000 | 347,000 | | Interest Expense | (164,000) | 81,000 | 83,000 | 88,000 | | Income Before Tax | 528,000 | 1,216,000 | 760,000 | 259,000 | | Income Tax Expense | 185,000 | 457,000 | 284,000 | 97,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 343,000 | 759,000 | 476,000 | 162,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 343,000 | 759,000 | 476,000 | 162,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $343,000 | $759,000 | $476,000 | $162,000 |
|
0.02% Nasdaq 
Income Statement
